Daprodustat: Ph III started

GlaxoSmithKline began the open-label, U.S. Phase III ASCEND-D trial to compare oral daprodustat

Read the full 134 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE